Biobank for studying pregnancy complications like preeclampsia and preterm birth
Biobank of Data and of Human Biological Samples on Prematurity, Preeclampsia and Other Pregnancy Complications
CHU de Quebec-Universite Laval · NCT02744365
This study collects samples and information from pregnant women to see if it can help identify the causes of complications like preeclampsia and preterm birth.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 7845 (estimated) |
| Ages | 18 Years and up |
| Sex | Female |
| Sponsor | CHU de Quebec-Universite Laval (other) |
| Locations | 1 site (Québec) |
| Trial ID | NCT02744365 on ClinicalTrials.gov |
What this trial studies
This biobank collects and stores data and biological samples from women participating in various studies related to pregnancy complications, including preeclampsia and preterm birth. It includes medical, social, obstetrical, and ultrasonographic data, as well as human biological samples such as maternal plasma and cord blood. The goal is to analyze these samples and data to identify risk factors and markers associated with pregnancy complications. This observational approach allows for a comprehensive understanding of the conditions affecting pregnancy outcomes.
Who should consider this trial
Good fit: Ideal candidates for this study are pregnant women who are able to provide informed consent and meet specific inclusion criteria from the original studies.
Not a fit: Patients who are under 18 years old, have a negative fetal heart rate at recruitment, or cannot provide informed consent will not benefit from this study.
Why it matters
Potential benefit: If successful, this biobank could lead to improved prediction and management of pregnancy complications, enhancing maternal and fetal health.
How similar studies have performed: Other studies focusing on biobanks for pregnancy complications have shown promise in identifying risk factors and improving outcomes, suggesting this approach is supported by previous successes.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * (specific to each study) Exclusion Criteria: * pregnant women \<18 years old at recruitment * negative fetal heart at recruitment * women not able to provide an informed consent to the study
Where this trial is running
Québec
- CHU de Quebec — Québec, Canada (RECRUITING)
Study contacts
- Principal investigator: Emmanuel Bujold, MD, MSc — CHU de Quebec
- Study coordinator: Emmanuel Bujold, MD, MSc
- Email: emmanuel.bujold@crchudequebec.ulaval.ca
- Phone: 418-525-4444
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Preeclampsia, Preterm Birth, Pregnancy Complications, Fetal Anomalies